Literature DB >> 7901016

Epstein-Barr virus infection in HIV-positive patients.

A Telenti1, D E Uehlinger, F Marchesi, D Germann, R Malinverni, L Matter.   

Abstract

The relationship between Epstein-Barr virus (EBV) viral load in peripheral blood and HIV infection was determined in 103 HIV-infected patients. Epstein-Barr virus was detected by polymerase chain reaction in 75% of the patients, 21% of whom had the more uncommon EBV subtype 2. The highest levels of EBV were found in patients with 100-400 CD4+ cells/mm3 and not in those with more profound immunosuppression. An association was identified between EBV load and HIV proviral levels (p < 0.001), an IgM response to EBV early antigens (p < or = 0.01) and p24 antigenemia (p < 0.01 in patients with > 100 CD4+ cells), but not with other clinical or laboratory parameters. Combinations of different EBV and HIV parameters identified a subgroup of patients with a 2.2- to 4.8-fold risk of > or = 35% decline in CD4+ counts over six months. The association between EBV and HIV markers may reflect a significant pathogenic interaction between the two viruses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901016     DOI: 10.1007/bf01973638

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  39 in total

Review 1.  Management of the hematologic complications of human immunodeficiency virus infection.

Authors:  J E Groopman
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

2.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion.

Authors:  J S Greenspan; D Greenspan; E T Lennette; D I Abrams; M A Conant; V Petersen; U K Freese
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

4.  Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

Authors:  D L Birx; R R Redfield; G Tosato
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

5.  Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.

Authors:  B Z Katz; N Raab-Traub; G Miller
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

6.  Is persistent polyclonal B lymphocytosis caused by Epstein-Barr virus? A study with polymerase chain reaction and in situ hybridization.

Authors:  K C Chow; J Q Nacilla; T E Witzig; C Y Li
Journal:  Am J Hematol       Date:  1992-12       Impact factor: 10.047

7.  Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma.

Authors:  M J Boyle; W A Sewell; T B Sculley; A Apolloni; J J Turner; C E Swanson; R Penny; D A Cooper
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

Review 8.  Molecular pathogenesis of HIV-associated lymphomas.

Authors:  P Ballerini; G Gaidano; J Gong; V Tassi; G Saglio; D M Knowles; R Dalla-Favera
Journal:  AIDS Res Hum Retroviruses       Date:  1992-05       Impact factor: 2.205

9.  A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection.

Authors:  J W Sixbey; P Shirley; M Sloas; N Raab-Traub; V Israele
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

10.  An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.

Authors:  S Kenney; J Kamine; D Markovitz; R Fenrick; J Pagano
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  7 in total

1.  The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene.

Authors:  Asako Kawaguchi; Kyosuke Kanai; Yukio Satoh; Chizu Touge; Keiko Nagata; Takeshi Sairenji; Yoshitsugu Inoue
Journal:  Virus Genes       Date:  2009-01-20       Impact factor: 2.332

2.  Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis.

Authors:  H D Stahl; B Hubner; B Seidl; U G Liebert; I M van der Heijden; B Wilbrink; M C Kraan; F Emmrich; P P Tak
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

3.  Anti-EBNA1/anti-EBNA2 ratio decreases significantly in patients with progression of HIV infection.

Authors:  B Winkelspecht; F Grässer; H W Pees; N Mueller-Lantzsch
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs.

Authors:  M C Meyohas; V Maréchal; N Desire; J Bouillie; J Frottier; J C Nicolas
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

5.  Detection of human immunodeficiency virus (HIV) type 1 antibodies by new automated microparticle enzyme immunoassay for HIV types 1 and 2.

Authors:  L Matter; D Germann
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation.

Authors:  Emilie Zuercher; Christophe Butticaz; Josiane Wyniger; Raquel Martinez; Manuel Battegay; Emmanuelle Boffi El Amari; Thanh Dang; Jean-François Egger; Jan Fehr; Esther Mueller-Garamvögyi; Andrea Parini; Stephan C Schaefer; Franziska Schoeni-Affolter; Christine Thurnheer; Marianne Tinguely; Amalio Telenti; Sylvia Rothenberger
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

7.  The blood DNA virome in 8,000 humans.

Authors:  Ahmed Moustafa; Chao Xie; Ewen Kirkness; William Biggs; Emily Wong; Yaron Turpaz; Kenneth Bloom; Eric Delwart; Karen E Nelson; J Craig Venter; Amalio Telenti
Journal:  PLoS Pathog       Date:  2017-03-22       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.